All posts tagged
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
More News! Smart Lens looks More Distant & a Pollen Allergy Cure?
French Biotech gets a Boost in the NASH Race with a Successful IPO
Not to be Underestimated: What’s the Hype around NASH?
Top European VC and CRO fund Young Metabolic Disease Biotech
Shire sells its RNA platform to a US-based Biotech
This British Biotech is buying its way into the Crowded NASH Space
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”
Green Light for Genfit to Tackle another Liver Disease
Novo Nordisk pressured into Dropping Needle-Free Oral Insulin
Genfit raises €45M and gets Closer to the First NASH Cure
Labiotech UG, All Rights Reserved -
Send this to friend